5 Reasons To Elevate Your Business With Sciton’s Award-Winning HALO® Laser

April 5, 2023—Are you looking to grow your practice with in-demand laser treatments from a respected and trusted laser company? If so, now is a perfect time. Keep reading for the top 5 reasons to elevate your business with Sciton’s HALO® laser.

Rapid growth and demand for energy-based aesthetic devices

The demand for aesthetic treatments is stronger than ever and climbing steadily. In 2022, the global medical aesthetics market grew 13% and is projected to reach $15.63 billion by 2026. 1  

The HALO laser, popular among patients and providers, has established strong consumer brand recognition over the past decade. This multi-award-winning hybrid fractional laser for glowing skin has recently been named the 2023 New Beauty award winner for Best Multitasking Laser.

Skin revitalization for patients of all skin types

HALO simultaneously targets multiple skin concerns on all skin types, including the appearance of:

  • Fine lines and wrinkles
  • Hyperpigmentation
  • Acne scars
  • Enlarged pores
  • Skin dullness
  • Pigmented lesions

It’s the first hybrid laser to deliver a non-ablative 1470 nm and ablative 2940 nm wavelength to the same microscopic treatment zone for an unmatched improvement in the appearance of aging skin.

Clinicians who perform HALO see consistent, predictable results in just one to two treatments vs. three to five traditional non-ablative resurfacing treatments.

According to RealSelf.com, a leading review site for cosmetic procedures, HALO has hundreds of positive reviews and before and after images. Patients have even coined the phrase “HALO glow” to describe their flawless complexion after treatment.

Dermatologist and HALO owner Arisa Ortiz says, “My patients love the HALO procedure. They always tell me their friends comment on how nice their skin looks after HALO. They look a lot brighter because the light reflects better off their skin.”

Halo laser treatment before and after photos - 6 weeks after 1 treatment


Maximum ROI and high-net revenue

High patient satisfaction isn’t the only reason practices invest in HALO. This multi-tasking laser is also Sciton’s highest net revenue fractional procedure ensuring maximum return on investment.

According to data from Sciton iQ™, a proprietary, real-time treatment analytics system, Sciton customers across the U.S. earn, on average, 4x their monthly lease payment in revenue. 2

Data also shows HALO has more than 2x higher consult requests than others in the facial laser category, and HALO owners earn 59% higher revenue per treatment than top facial laser competitors.3

It gets better.

Exponential results and earnings with ScitonStaX™

When combined with other award-winning Sciton treatments on the JOULE® multi-application system, such as BBL® HERO™—Sciton’s award-winning BroadBand Light® (BBL®) device for sun damage and hyperpigmentation—HALO owners further increase their revenue while dramatically improving patient outcomes. ScitonStaX combines up to three synergistic modalities on a Sciton platform to deliver stunning outcomes in a single session.

The JOULE, Sciton’s flagship platform, provides an extensive selection of aesthetic, medical, and surgical treatment options within a single, comprehensive system. The platform features more than ten laser and light-based modalities to address:

  • Aging skin
  • Photodamage
  • Scars
  • Vascular issues
  • Unwanted hair
Profitable and reliable systems

Designed, manufactured, and assembled by hand at Sciton’s company headquarters in Palo Alto, California, Sciton systems are built to last.

In fact, 96% of all Sciton systems sold in the past 10 years are still in service today. It’s yet another testament to the company’s commitment to quality and exceptional craftsmanship.

Ready to partner with a leader in medical laser aesthetics?

Speak to an expert today about expanding your practice with a Sciton system.



1Business Wire: Medical Aesthetics Global Market Report 2022: Growing Adoption of Non-Invasive and Minimally Invasive Procedures 

2,3Internal Sciton iQ data